Alan Venook, MD, Shorenstein Associate Director for Program Development, Helen Diller Family Comprehensive Cancer Center, Professor, Department of Medicine, UCSF, Discusses The Latest In Identifying Valid Biomarkers In The Treatment Of HCC. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019.
The Latest In Identifying Valid Biomarkers In The Treatment Of HCC
